Brief: AstraZeneca Says Datroway Approved In US For 1L Triple-Negative BC
May 26 (Reuters) - AstraZeneca PLC AZN.L: ASTRAZENECA PLC - DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC ASTRAZENECA - FDA APPROVAL OF DATROWAY FOLLOWS PRIORITY REVIEW BASED ON PHASE III DATA Source text: ID:nRSZ6558Fa Further company coverage: AZN.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains